These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Long-term therapy of vascular permeability disorders using anthocyanosides]. Neumann L Munch Med Wochenschr; 1973 May; 115(20):952-4. PubMed ID: 4740456 [No Abstract] [Full Text] [Related]
6. Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy. Berthet P; Farine JC; Barras JP Int J Clin Pract; 1999 Dec; 53(8):631-6. PubMed ID: 10692760 [TBL] [Abstract][Full Text] [Related]
7. [Haemodynamics and diabetic retinopathy]. Blum M; Eichhorn M; Vilser W Klin Monbl Augenheilkd; 2005 Jun; 222(6):463-70. PubMed ID: 15973624 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of diabetic retinopathy with laser photocoagulation (author's transl)]. Coscas G; Chaine G Diabete Metab; 1979 Sep; 5(3):247-59. PubMed ID: 387489 [TBL] [Abstract][Full Text] [Related]
9. [Diabetic retinopathy. Facts and speculations]. Freyler H Wien Med Wochenschr; 1979 Sep; 129(15):415-8. PubMed ID: 388887 [No Abstract] [Full Text] [Related]
10. [An experimental study on the role of vascular permeability in the development and progression of diabetic retinopathy (author's transl)]. Ishibashi T; Tanaka K; Taniguchi Y Nippon Ganka Gakkai Zasshi; 1979 Jul; 83(7):783-94. PubMed ID: 495365 [No Abstract] [Full Text] [Related]
11. Retinal sensitivity loss and structural disturbance in areas of capillary nonperfusion of eyes with diabetic retinopathy. Unoki N; Nishijima K; Sakamoto A; Kita M; Watanabe D; Hangai M; Kimura T; Kawagoe N; Ohta M; Yoshimura N Am J Ophthalmol; 2007 Nov; 144(5):755-760. PubMed ID: 17868632 [TBL] [Abstract][Full Text] [Related]
12. [Topographic aspects of the progression of diabetic retinopathy (an experimental set-up for the evaluation of medical influencability) (author's transl)]. Freyler H; Klemen U Klin Monbl Augenheilkd; 1981 May; 178(5):350-4. PubMed ID: 7253524 [TBL] [Abstract][Full Text] [Related]
13. [Diabetic angiopathies]. Alexander K Munch Med Wochenschr; 1970 Apr; 112(5):690-6. PubMed ID: 5538040 [No Abstract] [Full Text] [Related]
14. [Pathogenesis and treatment of diabetic retinopathy (author's transl)]. Freyler H Klin Monbl Augenheilkd; 1976 May; 168(05):661-72. PubMed ID: 957562 [TBL] [Abstract][Full Text] [Related]
15. Visual field defects in retinal disease. Harrington DO UCLA Forum Med Sci; 1969; 8():485-512. PubMed ID: 5397392 [No Abstract] [Full Text] [Related]
16. [Anthocyanosides in the treatment of retinopathies (author's transl)]. Scharrer A; Ober M Klin Monbl Augenheilkd; 1981 May; 178(5):386-9. PubMed ID: 7253530 [TBL] [Abstract][Full Text] [Related]
17. Retinal vascular disorders: nursing and medical implications. Brown MM Nurs Clin North Am; 1981; 16(3):415-32. PubMed ID: 6913946 [No Abstract] [Full Text] [Related]
18. [Diabetic retinopathy (angiopathy) of 20 years' standing (author's transl)]. Fischer F Wien Klin Wochenschr; 1974 Nov; 86(20):624-6. PubMed ID: 4418125 [No Abstract] [Full Text] [Related]
19. [Review on the retina in 1968. Retinal vascular diseases]. Matsui M Ganka; 1970 Jan; 12(1):1-24. PubMed ID: 4904738 [No Abstract] [Full Text] [Related]
20. Systemic and periocular deliveries of plasminogen kringle 5 reduce vascular leakage in rat models of oxygen-induced retinopathy and diabetes. Zhang SX; Sima J; Wang JJ; Shao C; Fant J; Ma JX Curr Eye Res; 2005 Aug; 30(8):681-9. PubMed ID: 16109649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]